ACE and angioedema: By contrast, ACE inhibitors, although well known to induce bradykinin-mediated angioedema, showed no association with the chronic, mast cell–mediated phenotype examined in this cohort, supporting mechanistic heterogeneity within angioedema syndromes [25].